NCT06216028View on ClinicalTrials.gov

Bone Marrow Aspirate Concentrate (BMAC) Treatment for Knee Osteoarthritis

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

374

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions
Knee OsteoarthritisMusculoskeletal Diseases
Interventions
BIOLOGICAL

Autologous Bone Marrow Aspirate Concentrate

Range of between 18.7 X 104 cells/mL and 21.8 X 106 cells/mL total nucleated cells (TNC)

Trial Locations (1)

Unknown

Canadian Centres for Regenerative Therapy (CCRT), Toronto

Sponsors
All Listed Sponsors
lead

CELL Technologies Inc.

INDUSTRY